27 patient trial in Thailand is hardly news worthy when other phase 2 HIV-1 trials are done with around 300 to 600 patients imo.
"This trial shows for the first time that there may be a way to clear one of the main cellular reservoirs. "
There is only a cure if all cellular reservoirs are cleared not just one.
"Higher levels of sCD163 are linked with worse clinical outcomes in patients. This reduction of sCD163 by BIT225 may provide additional clinical benefit in these patients. "
Once again 27 patients tested and only "may provide clinical benefit" , and half with placebo. So results from 13 or 14 patients. Hardly partner material imo.
$10 Billion Deal, page-134
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
0.002(3.70%) |
Mkt cap ! $50.52M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.6¢ | 5.2¢ | $51.10K | 945.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4281 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 625000 | 2 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
5.6¢ |
Change
0.002 ( 3.70 %) |
||||
| Open | High | Low | Volume | ||
| 5.2¢ | 5.6¢ | 5.2¢ | 183067 | ||
| Last updated 15.53pm 06/05/2024 ? | |||||
| BIT (ASX) Chart |